235 related articles for article (PubMed ID: 7926307)
1. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells.
Schnedl WJ; Ferber S; Johnson JH; Newgard CB
Diabetes; 1994 Nov; 43(11):1326-33. PubMed ID: 7926307
[TBL] [Abstract][Full Text] [Related]
2. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
[TBL] [Abstract][Full Text] [Related]
3. Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-D-glucose.
Wang Z; Gleichmann H
Exp Clin Endocrinol Diabetes; 1995; 103 Suppl 2():83-97. PubMed ID: 8839260
[TBL] [Abstract][Full Text] [Related]
4. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin.
Hosokawa M; Dolci W; Thorens B
Biochem Biophys Res Commun; 2001 Dec; 289(5):1114-7. PubMed ID: 11741307
[TBL] [Abstract][Full Text] [Related]
5. KATP channel-deficient pancreatic beta-cells are streptozotocin resistant because of lower GLUT2 activity.
Xu J; Zhang L; Chou A; Allaby T; Bélanger G; Radziuk J; Jasmin BJ; Miki T; Seino S; Renaud JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E326-35. PubMed ID: 18042662
[TBL] [Abstract][Full Text] [Related]
6. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
Wang Z; Gleichmann H
Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
[TBL] [Abstract][Full Text] [Related]
7. Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression.
Clark SA; Quaade C; Constandy H; Hansen P; Halban P; Ferber S; Newgard CB; Normington K
Diabetes; 1997 Jun; 46(6):958-67. PubMed ID: 9166666
[TBL] [Abstract][Full Text] [Related]
8. GLUT2 surface expression and intracellular transport via the constitutive pathway in pancreatic beta cells and insulinoma: evidence for a block in trans-Golgi network exit by brefeldin A.
Thorens B; Gérard N; Dériaz N
J Cell Biol; 1993 Dec; 123(6 Pt 2):1687-94. PubMed ID: 8276890
[TBL] [Abstract][Full Text] [Related]
9. Regulation of insulin secretion from novel engineered insulinoma cell lines.
Hohmeier HE; BeltrandelRio H; Clark SA; Henkel-Rieger R; Normington K; Newgard CB
Diabetes; 1997 Jun; 46(6):968-77. PubMed ID: 9166667
[TBL] [Abstract][Full Text] [Related]
10. Characterizing pancreatic β-cell heterogeneity in the streptozotocin model by single-cell transcriptomic analysis.
Feng Y; Qiu WL; Yu XX; Zhang Y; He MY; Li LC; Yang L; Zhang W; Franti M; Ye J; Hoeck JD; Xu CR
Mol Metab; 2020 Jul; 37():100982. PubMed ID: 32247924
[TBL] [Abstract][Full Text] [Related]
11. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
12. Streptozotocin-induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and beta-cell plasticity.
Dufrane D; van Steenberghe M; Guiot Y; Goebbels RM; Saliez A; Gianello P
Transplantation; 2006 Jan; 81(1):36-45. PubMed ID: 16421474
[TBL] [Abstract][Full Text] [Related]
13. Glucose uptake, utilization, and signaling in GLUT2-null islets.
Guillam MT; Dupraz P; Thorens B
Diabetes; 2000 Sep; 49(9):1485-91. PubMed ID: 10969832
[TBL] [Abstract][Full Text] [Related]
14. Scoparia dulcis, a traditional antidiabetic plant, protects against streptozotocin induced oxidative stress and apoptosis in vitro and in vivo.
Latha M; Pari L; Sitasawad S; Bhonde R
J Biochem Mol Toxicol; 2004; 18(5):261-72. PubMed ID: 15549711
[TBL] [Abstract][Full Text] [Related]
15. Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin.
Elsner M; Guldbakke B; Tiedge M; Munday R; Lenzen S
Diabetologia; 2000 Dec; 43(12):1528-33. PubMed ID: 11151762
[TBL] [Abstract][Full Text] [Related]
16. Differential metabolite accumulation may be the cause of strain differences in sensitivity to streptozotocin-induced beta cell death in inbred mice.
Cardinal JW; Allan DJ; Cameron DP
Endocrinology; 1998 Jun; 139(6):2885-91. PubMed ID: 9607798
[TBL] [Abstract][Full Text] [Related]
17. Importance of the GLUT2 glucose transporter for pancreatic beta cell toxicity of alloxan.
Elsner M; Tiedge M; Guldbakke B; Munday R; Lenzen S
Diabetologia; 2002 Nov; 45(11):1542-9. PubMed ID: 12436338
[TBL] [Abstract][Full Text] [Related]
18. Molecular target structures in alloxan-induced diabetes in mice.
im Walde SS; Dohle C; Schott-Ohly P; Gleichmann H
Life Sci; 2002 Aug; 71(14):1681-94. PubMed ID: 12137914
[TBL] [Abstract][Full Text] [Related]
19. GLUT1 is adequate for glucose uptake in GLUT2-deficient insulin-releasing beta-cells.
Liang Y; Cushman SM; Whitesell RR; Matschinsky FM
Horm Metab Res; 1997 Jun; 29(6):255-60. PubMed ID: 9230344
[TBL] [Abstract][Full Text] [Related]
20. Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose.
Yasuda K; Yamada Y; Inagaki N; Yano H; Okamoto Y; Tsuji K; Fukumoto H; Imura H; Seino S; Seino Y
Diabetes; 1992 Jan; 41(1):76-81. PubMed ID: 1370154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
